Comparative efficacy of switching to natalizumab in active multiple sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 2328-9503|2|4|373-387

ISSN： 2328-9503

Source： Annals Of Clinical And Translational Neurology, Vol.2, Iss.4, 2015-04, pp. : 373-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Treatment with Natalizumab on Ability to Work in People with Multiple Sclerosis: Productivity Gain Based on Direct Measurement of Work Capacity before and after 1 Year of Treatment

By Olofsson Sara  

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 299-306

Adis International

Access to resources Recommend Favorite

Treatment of Multiple Sclerosis with the Interferon- s: Comparative Risks and Benefits

By Herndon R.M.  

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 463-470

Adis International

Access to resources Recommend Favorite

Recombinant Interferon- -1a: A Review of its Therapeutic Efficacy in Relapsing-Remitting Multiple Sclerosis

By Wagstaff A.J.   Goa K.L.  

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 471-494

Adis International

Access to resources Recommend Favorite

Multiple sclerosis: pregnancy and motherhood

By Anderson Joanna   Wallace Louise  

The Practising Midwife, Vol. 16, Iss. 6, 2013-06 ,pp. : 28-31

Medical Education Solutions Limited

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in Multiple Sclerosis

By Achiron A.  

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 465-475

Adis International

Access to resources Recommend Favorite